The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Stem Cell Umbilical Cord Blood Market Increase Between 2026 And 2030?
The stem cell umbilical cord blood market has seen substantial growth in recent years. It is anticipated to increase from $7.98 billion in 2025 to $9.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.7%. This expansion during the preceding period is attributable to factors such as the heightened application of stem cell transplants, the broadening reach of public cord blood banks, progress in hematological treatments, greater awareness of stem cell therapies, and improvements in neonatal healthcare infrastructure.
The stem cell umbilical cord blood market size is projected to experience swift expansion in the coming years. This market is anticipated to reach $17.83 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.4%. Factors contributing to this growth during the forecast period include a heightened demand for tailored regenerative therapies, increased investments in cell therapy research, broader applications in treatments for neurological and immune disorders, a surge in the adoption of hybrid banking models, and progress in stem cell expansion technologies. Key trends identified for the forecast timeframe encompass the increasing integration of advanced cryopreservation techniques, a greater use of stem cells in regenerative medicine, the expanding scope of private cord blood banking services, an intensified emphasis on maintaining cell quality and viability, and the proliferation of hybrid cord blood storage solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp
Which Strategic Drivers Are Supporting The Stem Cell Umbilical Cord Blood Market Development?
Higher childbirth rates are anticipated to fuel future expansion within the stem cell umbilical cord blood market. Childbirth rates signify the count of live births per 1,000 individuals within a particular population during a defined timeframe, typically a single year. This rise in childbirth rates stems from the enhanced accessibility and reduced cost of fertility treatments, empowering more families to conceive. Umbilical cord blood stem cells hold significant value for infants because they contain hematopoietic stem cells, capable of addressing diverse blood, immune, and genetic conditions. Such cells offer an exact genetic compatibility for the baby and can potentially benefit siblings or other relatives. For example, data from April 2025, released by the U.S. Centers for Disease Control and Prevention, a federal agency in the USA, indicated that births in the USA climbed from 3,596,017 in 2023 to 3,622,673 in 2024, representing a 1% increase. Consequently, the upward trend in childbirth rates is a primary catalyst for the expansion of the stem cell umbilical cord blood market.
What Are The Major Segment Categories Within The Stem Cell Umbilical Cord Blood Market?
The stem cell umbilical cord blood market covered in this report is segmented –
1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation
3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
Subsegments:
1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells
Which Trends Are Influencing The Direction Of The Stem Cell Umbilical Cord Blood Market?
Leading companies in the stem cell therapy for multiple sclerosis market are prioritizing the creation of advanced products, including adipose-derived mesenchymal stem cells, to improve the effectiveness, safety, and regenerative capacity of therapies for patients experiencing relapsing-remitting and progressive types of multiple sclerosis. Adipose-derived mesenchymal stem cells (ADMSCs), multipotent cells sourced from adipose (fat) tissue, possess the capability to differentiate into various cell types and display regenerative and immunomodulatory characteristics that are advantageous in addressing autoimmune and neurodegenerative conditions like multiple sclerosis. For example, in August 2025, Hope Biosciences, LLC, a biopharmaceutical company located in the US, launched its HB-adMSCs therapy, which involves the use of adipose-derived mesenchymal stem cells given through high-dose infusions and subsequent doses over a 32-week period. This therapy integrates immunomodulatory and neuroregenerative mechanisms, providing the potential to decelerate disease advancement and mend myelin damage, thereby setting it apart from standard immunosuppressive treatments.
Which Companies Are Engaged In The Stem Cell Umbilical Cord Blood Market Environment?
Major companies operating in the stem cell umbilical cord blood market are Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co Ltd, Smart Cells International Ltd, StemCyte Inc, Celularity Inc, Next Biosciences Pty Ltd, Esperite NV, Cryo Cell International Inc, FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt Ltd, Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc, Cord Blood Registry, LifeCell International Pvt Ltd, CryoSave India Pvt Ltd
Access The Complete Stem Cell Umbilical Cord Blood Market Report:
Which Region Holds The Largest Share In The Stem Cell Umbilical Cord Blood Market?
North America was the largest region in the stem cell umbilical cord blood market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Stem Cell Umbilical Cord Blood Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp
Browse Through More Reports Similar to the Global Stem Cell Umbilical Cord Blood Market 2026, By The Business Research Company
Stem Cell Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report
Stem Cells Therapy Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Stem Cell Assay Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model